What is an antitrust ruling? How competition regulators shape UK and global M&A

An antitrust ruling is a formal decision by a competition regulator on whether a proposed merger, acquisition, or business practice restricts competition in a way that harms consumers or markets. The term covers a range of regulatory outcomes, from unconditional clearance to conditional approval with remedies to outright prohibition. In the context of M&A, antitrust rulings are one of the most significant external risks that dealmakers face, and understanding how the process works is important for anyone following corporate deal activity.

How antitrust review works in the UK

In the UK, merger control is handled by the Competition and Markets Authority. The CMA reviews deals that meet certain thresholds: broadly, where the combined entity would have a UK market share above 25 percent, or where the target has UK turnover above a threshold that has been updated to reflect digital markets more accurately. The CMA can also review deals below these thresholds if it has reasonable grounds to suspect a competition concern.

The process runs in two phases. Phase 1 is an initial review lasting around 40 working days, at the end of which the CMA either clears the deal unconditionally, clears it subject to undertakings, or refers it to Phase 2 for a deeper investigation. Phase 2 is a more intensive review, typically lasting up to 24 weeks, conducted by an independent inquiry group within the CMA. Phase 2 can result in clearance, conditional clearance with structural or behavioural remedies, or prohibition.

The CMA has become materially more interventionist since 2020. The proportion of deals subject to Phase 2 investigation has risen, and the willingness to impose remedies or prohibit deals, including cross-border deals with UK market exposure, has increased. For large deals with UK competition implications, CMA risk is now a core part of deal structuring rather than an afterthought.

How antitrust review works in the US

In the United States, merger review is split between the Department of Justice Antitrust Division and the Federal Trade Commission, depending on the sector. Both have authority to challenge deals under the Sherman Act and the Clayton Act. The Hart-Scott-Rodino Act requires pre-merger notification for deals above a certain size, triggering a waiting period during which the regulators can issue a second request for additional information if they have concerns.

US antitrust enforcement has also become more assertive in recent years, particularly in technology, healthcare, and financial services. The FTC and DOJ have both challenged deals that would previously have received clearance, and courts have occasionally sided with the regulators in high-profile cases. For deals involving US companies or significant US market presence, the timeline and risk profile of regulatory clearance have extended considerably.

What antitrust rulings mean for deals

Conditional clearance is the most common outcome for deals that face antitrust scrutiny. Regulators typically require the parties to divest certain businesses or assets, implement behavioural commitments such as pricing or access obligations, or accept ongoing monitoring by an independent trustee. These remedies are designed to restore the competitive conditions that the merger would otherwise have reduced.

Prohibition is rarer but consequential. Prohibited deals cannot proceed as structured, and parties either abandon the transaction or attempt to restructure it in a way that addresses the competition concerns. Breakup fees, which are contractual payments from the acquirer to the target if a deal fails due to regulatory prohibition, are now standard in transactions with material antitrust risk.

For investors and businesses following M&A, antitrust rulings are often the decisive factor in whether a deal completes, at what valuation, and on what timeline. Briefed covers CMA and FTC decisions, as well as major EU and other jurisdictional rulings, as part of its daily M&A coverage. The full archive of M&A stories, including antitrust rulings by company and sector, is at briefedmedia.com/topics/mergers-and-acquisitions. Free, weekdays at 06:45.